Population pharmacokinetics of lidocaine administered during and after cardiac surgery

Yung Wei Hsu, Jacques Somma, Mark F. Newman, Joseph P. Mathew

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Objective: The objective of this study was to determine the pharmacokinetics of lidocaine in a 48-hour infusion in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Design: A retrospective substudy of a clinical trial assessing the efficacy of intravenous lidocaine for postoperative cognitive decline. Setting: A university hospital. Participants: Ninety-nine patients undergoing cardiac surgery with CPB. Interventions: After the induction of anesthesia, lidocaine was administered as a bolus of 1 mg/kg and followed by a continuous infusion at 4 mg/min for the 1st hour, 2 mg/min for the 2nd hour, and 1 mg/min for the next 46 hours. Measurements and Main Results: Blood samples were taken at baseline, the end of CPB, and 24 and 48 hours after CPB for the measurement of the plasma concentration of lidocaine. Lidocaine levels increased significantly over time despite a constant rate of infusion (p < 0.05). The pharmacokinetics of lidocaine was best described by a 2-compartment model, and body weight was found to be a significant factor for the volume of the central compartment and clearance. The final pharmacokinetic parameters were V 1(L) = 0.0619 (*)weight, V 2(L) = 187, CL 1 (L/min) = 0.00419 (*)weight, and CL 2 (L/min) = 8.92. Conclusions: A 2-compartment pharmacokinetic model best describes the plasma concentrations of a 48-hour lidocaine infusion in patients undergoing cardiac surgery with CPB. The inclusion of body weight as a covariate on clearance and central compartment improves the model. Lidocaine infusions should be dosed by body weight and decreased after 24 hours to avoid potential toxicity in long-term infusions.

Original languageEnglish
Pages (from-to)931-936
Number of pages6
JournalJournal of Cardiothoracic and Vascular Anesthesia
Issue number6
StatePublished - Dec 2011

Bibliographical note

Funding Information:
Supported in part by grants #9970128N (M.N.) from the American Heart Association and #M01-RR-30 from the National Institutes of Health .


  • cardiopulmonary bypass
  • lidocaine
  • pharmacokinetics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Population pharmacokinetics of lidocaine administered during and after cardiac surgery'. Together they form a unique fingerprint.

Cite this